Alterations in gene expression during sexual differentiation in androgen receptor knockout mice induced by environmental endocrine disruptors

Corrigendum in: /ijmm/35/4/1147

  • Authors:
    • Dehong Liu
    • Liping Shen
    • Yonglin Tao
    • Ying Kuang
    • Lei Cai
    • Dan Wang
    • Meiduo He
    • Xuebo Tong
    • Shuguang Zhou
    • Jie Sun
    • Chenchen Shi
    • Chunxiao Wang
    • Yi Wu
  • View Affiliations

  • Published online on: November 28, 2014     https://doi.org/10.3892/ijmm.2014.2015
  • Pages: 399-404
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In the present study, we aimed to explore the effect of environmental endocrine disruptors (EEDs) on sexual differentiation in androgen receptor (AR)-/-, AR+/- and AR+/+ male mice. By using a Cre-loxP conditional knockout strategy, we generated AR knockout mice. By mating flox-AR female mice with AR-Cre male mice, the offspring male mice which were produced were examined. Mice not subjected to any type of intervention were used as the controls. Furthermore, male mice of different genotypes were selected and further divided into subgroups as follows: the control group, bisphenol A (BPA) group and the D binding protein (DBP) group. The expression of the Wilms tumor 1 (WT1), lutropin/choriogonadotropin receptor (LHR), 17-β-hydroxysteroid dehydrogenase type 3 (17βHSD3) and steroid-5-alpha-reductase, alpha polypeptide 2 (SRD5A2) genes was determined by RT-qPCR and western blot analysis. There was no statistically significant difference in the weight of the mice between the control group and the knockout group (P>0.05). The results revealed that, compared with the control group, in the knockout group, anogenital distance was shortened, and testicular weight and testosterone levels were decreased; estradiol levels were elevated; the differences were statistically significant (P<0.05). In the group of AR+/- male mice exposed to 100 mg/l EEDs, hypospadias was successfully induced, suggesting that EEDs are involved in the embryonic stage of sexual development in male mice. The quantitative detection of WT1, LHR, 17βHSD3 and SRD5A2 gene expression by RT-qPCR and western blot analysis indicated that these genes were significantly downregulated in the mice in the BPA group. In conclusion, exposure to EEDs induces hypospadias in heterozygous and wild-type male mice offspring during sexual differentiation, but has no effect on homozygous offspring. Therefore, EEDs play an important role during the third stage of sexual differentiation.

Introduction

Endocrine disruption has become a critical issue in environmental science, particularly after the endocrine-disrupting chemical pollution accident in Taiwan which attracted public attention worldwide (1). Consequently, over the last few years, multi-disciplinary research programmes regarding this issue have been conducted in several countries. Several environmental chemicals with anti-androgenic activities that have the potential to disrupt normal male sexual differentiation in utero have recently been identified (2,3). The detection of chemicals with the potential to disrupt normal androgen function is critical for the protection of human and ecological health.

The androgen receptor (AR), a member of the nuclear receptor superfamily, is composed of 919 amino acids (4). It contains an N-terminal transactivation domain, a central DNA-binding domain and a C-terminal ligand-binding domain (5). AR may form a dimer and interact with many co-regulators to modulate androgen target genes (6). Previous studies have demonstrated that AR is involved in a series of developmental and physiological functions, particularly in male sexual differentiation (7), the maintenance of adolescent sexual maturation (8), sperm production (9) and male sex hormone regulation (10). The function of androgens is mediated by the AR (11). Research has indicated that, during the process of sexual development, the number and activity of ARs has direct effects on target organs, and thus plays a crucial role in the onset of hypospadias (12). Male sexual differentiation is the result of complex mechanisms involving developmental genetics and endocrinology. Hormone function is mediated through specific receptors, functioning as transcriptional regulators. The disruption of these genetic events leads to abnormal sexual dimorphism involving both external and internal genitalia, and may also interfere with the development of other organs (13).

Transgenic and knockout mice have long been used as animal models to study the function of genes in vivo. Testicular feminization in male mice and androgen insensitivity syndrome in human male patients are the common models used for the study of the loss of androgen function (14). To generate tissue-specific AR knockout (ARKO) mice or female ARKO mice, a Cre-loxP strategy for conditional knockout is required. The Cre-loxP system utilizes the expression of P1 phage cre recombinase (Cre) to catalyze the expression of DNA located between flanking loxP sites (15). This strategy differs from the standard targeted gene disruption procedure in that the embryonic stem (ES) cells are generated in which the targeted segment is not disrupted but flanked by loxP sites (floxed). Thus, the target gene functions normally and mice can be bred which are homozygous at the targeted locus.

In the present study, we describe the generation and characterization of ARKO mice. The potential in vivo application of this mouse model for the study of the effects of environmental endocrine disruptors (EEDs) on sexual differentiation in AR−/−, AR+/− and AR+/+ male mice is also discussed. We aimed to examine the role of EDDs in the third stage of sexual differentiation through the regulation of the expression of Wilms tumor 1 (WT1), lutropin/choriogonadotropin receptor (LHR), 17-β-hydroxysteroid dehydrogenase type 3 (17βHSD3) and steroid-5-alpha-reductase, alpha polypeptide 2 (SRD5A2) genes in AR−/−, AR+/− and AR+/+ male mice. The results of the present study may provide a theoretical basis for the development of future preventive strategies to reduce EED contact.

Materials and methods

All experiments were approved by the Ruijin Hospital Ethics Committee and were performed in accordance with ethical standards.

Materials

C57BL/6 mice, 35–40 days old, weighing 18–22 g, were supplied by the Shanghai SLAC Laboratory Animal Co., Ltd. (Shanghai, China). The mice were raised in an air-conditioned room under controlled lighting and were fed standard laboratory chow and water ad libitum. DNA polymerase was purchased from Toyobo Co. (Osaka, Japan), proteinase K was from Merck (Billerica, MA, USA) and kits for the detection of testosterone and estradiol were purchased from Amersham Biosciences Corp. (Piscataway, NJ, USA). Immunohistochemical staining kits were purchased from CapitalBio Corp. (Beijing, China) and bisphenol A (BPA) and D binding protein (DBP) were obtained from Sigma-Aldrich (St. Louis, MO, USA). Antibodies to LHR, 17βHSD3 and SRD5A2 were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).

Construction of targeting vector Amhr2-Cre

We designed the PCR primer 1 according to the Amhr2 promoter sequence previously reported (16). Genomic DNA from blood collected from the C57BL/6 mice was isolated as a template for PCR amplification. The amplified fragment has an expected size of 5 kb and was subcloned to the pMD18-T plasmid, and named Amhr5K-P-TV for further sequencing. The universal primer 2 was used to perform the amplification of bands of approximately 1 kb from Amhr5K-P-TV, and universal primer 3 was used to yield amplification bands of Cre approximately1 kb from the plasmid Aluminum-cre; both fragments were recycled. Recycling DNA was used as a template, and the reverse sequence of primer 2 and the forward sequence of primer 3 were used to perform the amplification of the 2 kb strip. The recycled 2 kb strip was digested with the HindIII and XbaI enzymes, and ligated with the pGL3-Basic plasmid digested with the same enzymes for further transfection. The identification of positive clones was carried out by PCR and the clone was named Amhr-1k CRE4. A fragment of 3 kb was amplified from plasmid Amhr5K-P-TV with primer 4, digested with the MluI and EcoRI enzymes and subcloned into the Amhr-1k-CRE4 clone (primer information is presented in Table I). Identification of positive clones was carried out by PCR and the clone was named Amhr-4k-CRE6 (8.2 KB). Following digestion with the EcoR, BamHⅠ, EcoRV and ScaⅠ enzymes, a promoter of 7.1 Kb was obtained which was connected to plasmid pRCH. The identification of the plasmid containing leydig cells expressing Cre recombinant enzyme and the specificity of the genetically modified (gm) sequence [Amhr2-Cre (7.1)] are shown in Fig. 1.

Table I

Primers used for the construction of target vectors, Amhr2-Cre.

Table I

Primers used for the construction of target vectors, Amhr2-Cre.

PrimerSequence
Primer 1Forward: 5′-AAAAGGACATTAAGACCACATAAT-3′
Reverse: 5′-GAAGCAGTGTCCAAAGCCCCCATG-3′
Primer 2Forward: 5′-CTCCAAGCTTCCTCTGCCTCTTGAGT-3′
Reverse: 5′-TGTACGGTCAGTAAATTGGACATAAACCAGCAAAAACCAG-3′
Primer 3Forward: 5′-CTGGTTTTTGCTGGTTTATGTCCAATTTACTGACCGTACA-3′
Reverse: 5′-AATCTCTAGACTAATCGCCATCTTCCAGCA-3′
Primer 4Forward: 5′-TACGACGCGTGCATCTGCCACTGTGCCTGG-3′
Reverse: 5′-CAGCCCGGACCGACGATGAA-3′
The microinjection of fertilized eggs

With the use of KpnI and SacI double enzyme digestion to construct the transgenic plasmid, the injection fragments were recycled. According to the conventional method, we performed microinjection and transplantation of the fertilized eggs.

Genotypic identification of genetically modified mice

Genomic DNA was extracted from the gonadal tissue of mice for PCR analysis. According to the gene sequence upstream and downstream of the Cre enzyme gene, we designed a pair of primers (primer 5: forward, TCTGTAGACTCTAGGCAGTTCCTGT and reverse, CAGCCCGGACCGACGATGAA). We employed this primer set to propagate the Cre enzyme gene of approximately 2,115 bp. The PCR reaction conditions were as follows: 95°C for 3 min; followed by 26 cycles of 95°C for 15 sec (denaturation) and 58°C (annealing temperature), 72°C for 2 min (elongation) and 72°C for 10 min.

Heterozygous female mice mating with Amhr2-Cre transgenic mice, the experimental groups and exposure to EEDs

Heterozygous female mice mated with Amhr2-Cre transgenic mice bred heterozygous mice of the F1 generation. The F1 generation was then backcrossed to C57BL/6 mice for 2 generations, which then produced pure strains of heterozygous mice. F1 generation transgenic mice were selfed, producing homozygous mice with a clear genetic background. Heterozygous female mice were mated with homozygous male mice and became pregnant. The mice were divided into the following groups: the control group (no intervention), the BPA group (100 mg/l/day, by gavage) and the DBP group (100 mg/kg/day, by gavage). The pregnant heterozygous female mice were exposed to EEDs (mice were administered either DBP at 100 mg/kg/day or BPA at 100 mg/l/day).

Reverse transcription-quantitative (real-time) PCR (RT-qPCR)

Total cellular RNA was prepared using TRIzol reagent (Invitrogen Life Technologies, Carlsbad, CA, USA) and the expression levels of WT1, LHR, 17βHSD3 and SRD5A2 were determined by real-time PCR using SYBR-Green. The data were normalized to GAPDH expression and represent the average of 3 independent experiments. The primer sequences were as follows: WT1 forward, 5′-CAAATGACATCCCAGCTTGA-3′ and reverse 5′-GACACCGTGCGTGTGTATTC-3′; LHR forward, 5′-ATATTCAAGAGATGCACTGTGCAG-3′ and reverse, 5′-AAGCAGAGTGTCAATGGGAAATAG-3′.

Western blot analysis

Western blot analysis was performed as previously described (17). Cell lysates were subjected to SDS-polyacrylamide gel electrophoresis and immunoblot analysis with antibodies to WT1, LHR, 17βHSD3 and SRD5A2 (all from Santa Cruz Biotechnology). Radioiodinated Staphylococcus protein A (IPA) was used as the antibody and β-actin was used as a control for normalization.

Results

Construction of transgenic mouse model (Amhr2-Cre)

The AR gene condition knockout plasmid was identified and confirmed by enzyme digestion with BamHI. Fig. 2 illustrates that 3 fragments with a size of 2.7, 3 and 2.7 kb were visible by agarose gel electrophoresis.

Breeding of chimeric mice

A total of 96 drug-resistant ES cell clones was identified by PCR; homologous recombination arms occurred in 5 ES clones (Fig. 3). PCR products confirmed by DNA sequencing further pointed out that there were only 2 positive clones, and these 2 positive ES clone blastocysts were injected and implanted in the uterus of pseudo-pregnant mice. The mice with a chimeric rate >50% were mated with C57BL/6 mice; thus, 6 F1 generation female mice with 2 ‘positive arms’ were produced.

Comparison between AR−/− male mice and normal mice

Maldevelopment, i.e. enlargement of the prostate, the seminal vesicles, the epididymis and the sponge balls was observed in the knockout mice. By contrast, in the control group, the prostate, the seminal vesicles, the epididymis and the ball sponges were normally developed. Comparisons regarding the anogenital distance, testicular weight, blood testosterone and estradiol concentrations were made between the control group and the knockout group as shown in Table II. There was no statistically significant difference in weight between these 2 groups (P>0.05). Compared with the control group, in the knockout group, the anogenital distance was significantly shortened, the testicular weight was significantly reduced, the testosterone levels were decreased and the estradiol levels were elevated; the differences were statistically significant (P<0.05).

Table II

Comparison of anogenital distance, testicular weight, blood testosterone levels and estradiol concentration between the 2 groups.

Table II

Comparison of anogenital distance, testicular weight, blood testosterone levels and estradiol concentration between the 2 groups.

IndexControl groupKnockout group
Weight (g)22.3±2.121.2±1.3
Anogenital distance (cm)1.2±0.10.5±0.1
Testicular weight (g)0.087±0.0020.005±0.001
Blood testosterone (nmol/l)0.87±0.5330.054±0.043
Estradiol concentration (nmol/l)796±1301386±280

[i] Data are presented as the means ± SD.

Heterozygoous mice mated with Amhr2-Cre transgenic mice, the experimental groups and exposure to EEDs

In the group of AR+/− male mice administered BPA (100 mg/l/day, by gavage) and DBP (100 mg/kg/day, by gavage) hypospadias was successfully induced, while the AR−/− mice did not have hypospadias. The detailed information is presented in Table III.

Table III

Incidence of hypospadias in AR+/− and AR−/− male mice exposed to EEDs.

Table III

Incidence of hypospadias in AR+/− and AR−/− male mice exposed to EEDs.

Exposure to EEDsAR+/− male mice/cases of hypospadiasAR−/− male mice/cases of hypospadias
BPA group32/3031/0
DBP group29/2633/0

[i] EEDs, environmental endocrine disruptors; BPA, bisphenol A; DBP, D binding protein.

Disorders of sexual development in male mice following exposure to EEDs

The 10-week-old offspring mice were euthanized by anesthesia (in mice, testicular descent into the scrotum occurs at 45–55 days, sexual maturity is reached in approximatley 70 days). Secondary sexual differentiation, cryptorchidism, genital malformation, testicular atrophy, hyperplasia of supporting cells and fibrous tissue hyperplasia were observed in the male heterozygous mice exposed to EEDs (Fig. 4). These results suggest that EEDs are involved in the embryonic stage of the sexual development of male mice and contribute to the occurrence of disorders of sexual developmental during the embryonic stage.

Exposure to EEDs downregulates gene expression in mice

Testicular tissue-specific expression was analyzed by RT-qPCR. The quantitative detection of WT1, LHR, 17βHSD3 and SRD5A2 gene expression in the mice exposed to EEDs (BPA and DBP) demonstrated that the expression of the aforementioned 4 genes was lower than that observed in the control group (non-exposed mice). The mRNA expression levels of WT1, LHR, 17βHSD3 and SRD5A2 in testicular tissue were the lowest in the BPA group and the highest in the control group (Fig. 5). These results suggest that EEDs are involved in the embryonic stage of the sexual development of male mice and contribute to the occurrence of disorders of sexual development. Western blot analysis was used for the detection of the protein expression of WT1, LHR, 17βHSD3 and SRD5A2 in testicular tissue. The results revealed that in the BPA and DBP groups, the expression levels of of the aforementioned 4 genes were lower than those in the control group. The protein expression levels of WT1, LHR, 17βHSD3 and SRD5A2 in testicular tissue were the lowest in the BPA group and the highest in the control group (Fig. 6).

Discussion

In recent years, the incidence of hypospadias has been gradually increasing. A great amount of research on a wide range of aspects, from the epidemiological to the genetic aspects of hypospadias, has been carried out (18,19). However, no consensus has yet been reached on this issue. Previous studies have suggested that the understanding of the normal development of the male external urethral orifice is an important step towards the understanding of the development of hypospadias (20,21). Research focusing on the normal embryonic development of the penile urethra has formed a basis for understanding the development and pathogenesis of hypospadias (22,23). By comparing the development of the urethra between humans and mice, scientists have found that the growth and development of the urethra are very similar between the two species during urethral seam formation (24). However, further studies are required to determine the association between AR expression and androgen signaling in males.

An increase in the incidence of hypospadias was reported in 1975 by the then newly established Norwegian Birth Defects Monitoring System (25). While the number of cases in that study was small (25), a continuation of this initial increase was subsequently reported by another study (26). Czeizel examined the rates of isolated hypospadia cases in Hungary between 1971 and 1983 and found that the incidence had increased significantly during this time period (P<0.01) (27). Matlai and Beral (28) examined the rates of malformations reported at birth and found a significant increase in cases of cryptorchidism, hypospadias and hydrocele between 1969 and 1983 in England and Wales (all P-values <0.001). Owing to the aggravating environmental pollution, the issue of developmental deformities has attracted public attention. However, the damage or defects that EEDs cause to the male reproductive system require further investigation. A number of scholars believe that the incidence of hypospadias in recent decades in males is strongly associated with the significant increase in exposure to EEDs, such as BPA and DBP, which exist in high levels in the environment (29,30). Existing research indicates that the male reproductive system is the target organ of EEDs, and that exposure to EEDs may result in significantly lower testosterone levels and can cause hypospadias, cryptorchidism, dysplasia of the epididymis and other male urogenital disorders (31).

Exposure to EEDs during the third stage of sexual development negatively affects the expression of genes related to male sexual development, such as WT1, LHR, 17βHSD3 and SRD5A2 at the transcriptional and translational level. The transcription factors, SF-1 and WT1, play a pivotal role in mammalian gonadal development and sexual differentiation. In human embryos, both SF-1 and WT1 are expressed when the gonadal ridge first forms at 32 days post-ovulation (32). As the sex cords develop, providing morphological evidence of testis differentiation, SF-1 localizes predominantly to developing Sertoli cells in the sex cords, whereas WT1 retains a broader pattern of expression (33). At later stages, SF-1 predominantly localizes to steroidogenic Leydig cells, and WT1 localizes to the sex cords (33). In the ovaries, SF-1 and WT1 transcripts persist in the gonadal ridge from the earliest developmental stages throughout the critical period of sex determination (33). Human male sexual development is regulated by chorionic gonadotropin and luteinizing hormone. The aberrant sexual development caused by both activating and inactivating mutations of human luteinizing hormone receptor (LHR) has been described. Constitutive activity of the LHR causes LH releasing hormone-independent precocious puberty in boys and the autosomal dominant disorder, familial male-limited precocious puberty (34). The 17βHSD3 gene on chromosome 9q22 contains 11 exons. Defects in the conversion of androstenedione to testosterone in the fetal testes by the enzyme, 17beta-hydroxysteroid dehydrogenase (17β-HSD), give rise to instances of individuals having female external genitalia despite being genetically male (35). Androgen production increases to normal progressively, so that testosterone and dihydrotestosterone concentrations are sufficiently high to gradually induce somatic and genital civilization, thus enabling an adequate male gender function (36). Prospective studies have suggested that the risk of developing prostate cancer may be increased in association with high serum concentrations of free testosterone and androstanediol glucuronide (Adiol G) (37,38). Polymorphisms have been identified in the 17-hydroxylase cytochrome P450 gene (CYP17) and SRD5A2, two genes that are involved in the biosynthesis and metabolism of androgens in males (39).

In conclusion, we successfully developed Amhr2-Cre genetically modified mice. Recombination between the LoxP loci in the genome for the application of the Cre-LoxP system was used to generate the knockout mice. Gene expression in testicular tissue was examined to determine its association with the development of hypospadias, cryptorchidism, small penis and testicles and other pediatric urological disorders. Our data indicate that the Cre recombinase is expressed in testicular tissue in Amhr2-Cre transgenic mice. These mice may serve as a useful tool for generating testis-specific gene knockout mice. The role of Cre recombinase in the development of disorders of the reproductive system may provide the ideal genetic tools for future research.

Acknowledgments

The present study was supported in part by grants from the National Natural Science Foundation of China (30700830), the Shanghai Hospital Science and Technology Resource Sharing Program Funded by the Shanghai Shenkang Hospital Development Center (SHDC12007708) and the Science and Technology Fund of Shanghai JiaoTong University School of Medicine (grant no. 06XJ21022). We thank the Shanghai Institute of Biochemistry and Cell Biology (SIBCB), the Shanghai Institutes for Biological Sciences (SIBS), the Chinese Academy of Sciences (CAS) and the Shanghai Research Center For Model Organisms. We are grateful to Yuan-Chang Yan, Yunbin Zhang, Jinjin Wang, Weijue Xu and Su Yan for their assistance in biochemical analysis and the animal experiments.

References

1 

Yang J, Hauser R and Goldman RH: Taiwan food scandal: the illegal use of phthalates as a clouding agent and their contribution to maternal exposure. Food Chem Toxicol. 58:362–368. 2013. View Article : Google Scholar : PubMed/NCBI

2 

Li X, Ye L, Wang X, et al: In silico investigations of anti-androgen activity of polychlorinated biphenyls. Chemosphere. 92:795–802. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Pan C, Wang Q, Liu YP, et al: Anti-androgen effects of the pyrethroid pesticide cypermethrin on interactions of androgen receptor with corepressors. Toxicology. 311:178–183. 2013. View Article : Google Scholar : PubMed/NCBI

4 

Steketee K, Timmerman L, Ziel-van der Made AC, Doesburg P, Brinkmann AO and Trapman J: Broadened ligand responsiveness of androgen receptor mutants obtained by random amino acid substitution of H874 and mutation hot spot T877 in prostate cancer. Int J Cancer. 100:309–317. 2002. View Article : Google Scholar : PubMed/NCBI

5 

Jenster G, van der Korput HA, Trapman J and Brinkmann AO: Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J Biol Chem. 270:7341–7346. 1995. View Article : Google Scholar : PubMed/NCBI

6 

Li J and Al-Azzawi F: Mechanism of androgen receptor action. Maturitas. 63:142–148. 2009. View Article : Google Scholar : PubMed/NCBI

7 

Bao AM and Swaab DF: Sexual differentiation of the human brain: relation to gender identity, sexual orientation and neuro-psychiatric disorders. Front Neuroendocrinol. 32:214–226. 2011. View Article : Google Scholar : PubMed/NCBI

8 

Raznahan A, Lee Y, Stidd R, et al: Longitudinally mapping the influence of sex and androgen signaling on the dynamics of human cortical maturation in adolescence. Proc Natl Acad Sci USA. 107:16988–16993. 2010. View Article : Google Scholar : PubMed/NCBI

9 

Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E and Georgiou I: Semen quality is influenced by androgen receptor and aromatase gene synergism. Hum Reprod. 27:3385–3392. 2012. View Article : Google Scholar : PubMed/NCBI

10 

Sarachana T, Xu M, Wu RC and Hu VW: Sex hormones in autism: androgens and estrogens differentially and reciprocally regulate RORA, a novel candidate gene for autism. PloS One. 6:e171162011. View Article : Google Scholar : PubMed/NCBI

11 

Heinlein CA and Chang C: Androgen receptor (AR) coregulators: an overview. Endocr Rev. 23:175–200. 2002. View Article : Google Scholar : PubMed/NCBI

12 

Wilhelm D and Koopman P: The makings of maleness: towards an integrated view of male sexual development. Nat Rev Genet. 7:620–631. 2006. View Article : Google Scholar : PubMed/NCBI

13 

Hiort O and Holterhus PM: The molecular basis of male sexual differentiation. Eur J Endocrinol. 142:101–110. 2000. View Article : Google Scholar : PubMed/NCBI

14 

Yeh S, Tsai MY, Xu Q, et al: Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proc Natl Acad Sci USA. 99:13498–13503. 2002. View Article : Google Scholar : PubMed/NCBI

15 

Holt CL and May GS: A novel phage λ replacement Cre-lox vector that has automatic subcloning capabilities. Gene. 133:95–97. 1993. View Article : Google Scholar : PubMed/NCBI

16 

Teixeira J, Kehas DJ, Antun R and Donahoe PK: Transcriptional regulation of the rat Müllerian inhibiting substance type II receptor in rodent Leydig cells. Proc Natl Acad Sci USA. 96:13831–13838. 1999. View Article : Google Scholar

17 

Burnette WN: ‘Western blotting’: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 112:195–203. 1981. View Article : Google Scholar : PubMed/NCBI

18 

Carmichael SL, Shaw GM, Nelson V, Selvin S, Torfs CP and Curry CJ: Hypospadias in California: trends and descriptive epidemiology. Epidemiology. 14:701–706. 2003. View Article : Google Scholar : PubMed/NCBI

19 

Kalfa N, Philibert P and Sultan C: Is hypospadias a genetic, endocrine or environmental disease, or still an unexplained malformation? Int J Androl. 32:187–197. 2009. View Article : Google Scholar

20 

Rey RA and Grinspon RP: Normal male sexual differentiation and aetiology of disorders of sex development. Best Pract Res Clin Endocrinol Metab. 25:221–238. 2011. View Article : Google Scholar : PubMed/NCBI

21 

Ching ST, Cunha GR, Baskin LS, Basson MA and Klein OD: Coordinated activity of Spry1 and Spry2 is required for normal development of the external genitalia. Dev Biol. 386:1–11. 2014. View Article : Google Scholar

22 

Qiao L, Tasian GE, Zhang H, et al: Androgen receptor is overexpressed in boys with severe hypospadias, and ZEB1 regulates androgen receptor expression in human foreskin cells. Pediatr Res. 71:393–398. 2012. View Article : Google Scholar : PubMed/NCBI

23 

Vottero A, Minari R, Viani I, et al: Evidence for epigenetic abnormalities of the androgen receptor gene in foreskin from children with hypospadias. J Clin Endocrinol Metab. 96:E1953–E1962. 2011. View Article : Google Scholar : PubMed/NCBI

24 

Bhoj EJ, Ramos P, Baker LA, et al: Human balanced translocation and mouse gene inactivation implicate Basonuclin 2 in distal urethral development. Eur J Hum Genet. 19:540–546. 2011. View Article : Google Scholar : PubMed/NCBI

25 

Miller JR: Some epidemiological aspects of teratogen detection. Mutat Res. 33:45–54. 1975. View Article : Google Scholar : PubMed/NCBI

26 

Parker A, Newell KW, Torfs M and Israel E: Appropriate tools for health care: developing a technology for primary health care and rural development. WHO Chron. 31:131–137. 1977.PubMed/NCBI

27 

Czeizel A, Toth J and Czvenits E: Increased birth prevalence of isolated hypospadias in Hungary. Acta Paediatr Hung. 27:329–337. 1985.

28 

Matlai P and Beral V: Trends in congenital malformations of external genitalia. Lancet. 325:1081985. View Article : Google Scholar

29 

Baskin LS, Himes K and Colborn T: Hypospadias and endocrine disruption: is there a connection? Environ Health Perspect. 109:11752001. View Article : Google Scholar : PubMed/NCBI

30 

Wang MH and Baskin LS: Endocrine: disruptors, genital development, and hypospadias. J Androl. 29:499–505. 2008. View Article : Google Scholar : PubMed/NCBI

31 

Dalsenter P, Santana G, Grande S, Andrade AJ and Araujo S: Phthalate affect the reproductive function and sexual behavior of male Wistar rats. Hum Exp Toxicol. 25:297–303. 2006. View Article : Google Scholar : PubMed/NCBI

32 

Nachtigal MW, Hirokawa Y, Enyeart-VanHouten DL, Flanagan JN, Hammer GD and Ingraham HA: Wilms’ tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell. 93:445–454. 1998. View Article : Google Scholar : PubMed/NCBI

33 

Hanley NA, Ball SG, Clement-Jones M, et al: Expression of steroidogenic factor 1 and Wilms’ tumour 1 during early human gonadal development and sex determination. Mech Dev. 87:175–180. 1999. View Article : Google Scholar : PubMed/NCBI

34 

Wu SM, Leschek EW, Rennert OM and Chan WY: Luteinizing hormone receptor mutations in disorders of sexual development and cancer. Fetal Pediatr Pathol. 19:21–40. 2000. View Article : Google Scholar

35 

Geissler WM, Davis DL, Wu L, et al: Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3. Nat Genet. 7:34–39. 1994. View Article : Google Scholar : PubMed/NCBI

36 

Rosler A: Steroid 17β-hydroxysteroid dehydrogenase deficiency in man: an inherited form of male pseudohermaphroditism. J Steroid Biochem Mol Biol. 43:989–1002. 1992. View Article : Google Scholar

37 

Parsons JK, Carter HB, Platz EA, Wright EJ, Landis P and Metter EJ: Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy. Cancer Epidemiol Biomarkers Prev. 14:2257–2260. 2005. View Article : Google Scholar : PubMed/NCBI

38 

Schatzl G, Madersbacher S, Thurridl T, Waldmueller J, Kramer G, Haitel A and Marberger M: High-grade prostate cancer is associated with low serum testosterone levels. Prostate. 47:52–58. 2001. View Article : Google Scholar : PubMed/NCBI

39 

Choi JH, Kim GH, Seo EJ, Kim KS, Kim SH and Yoo HW: Molecular analysis of the AR and SRD5A2 genes in patients with 46, XY disorders of sex development. J Pediatr Endocrinol Metab. 21:545–553. 2008.PubMed/NCBI

Related Articles

Journal Cover

February-2015
Volume 35 Issue 2

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu D, Shen L, Tao Y, Kuang Y, Cai L, Wang D, He M, Tong X, Zhou S, Sun J, Sun J, et al: Alterations in gene expression during sexual differentiation in androgen receptor knockout mice induced by environmental endocrine disruptors Corrigendum in /ijmm/35/4/1147. Int J Mol Med 35: 399-404, 2015
APA
Liu, D., Shen, L., Tao, Y., Kuang, Y., Cai, L., Wang, D. ... Wu, Y. (2015). Alterations in gene expression during sexual differentiation in androgen receptor knockout mice induced by environmental endocrine disruptors Corrigendum in /ijmm/35/4/1147. International Journal of Molecular Medicine, 35, 399-404. https://doi.org/10.3892/ijmm.2014.2015
MLA
Liu, D., Shen, L., Tao, Y., Kuang, Y., Cai, L., Wang, D., He, M., Tong, X., Zhou, S., Sun, J., Shi, C., Wang, C., Wu, Y."Alterations in gene expression during sexual differentiation in androgen receptor knockout mice induced by environmental endocrine disruptors Corrigendum in /ijmm/35/4/1147". International Journal of Molecular Medicine 35.2 (2015): 399-404.
Chicago
Liu, D., Shen, L., Tao, Y., Kuang, Y., Cai, L., Wang, D., He, M., Tong, X., Zhou, S., Sun, J., Shi, C., Wang, C., Wu, Y."Alterations in gene expression during sexual differentiation in androgen receptor knockout mice induced by environmental endocrine disruptors Corrigendum in /ijmm/35/4/1147". International Journal of Molecular Medicine 35, no. 2 (2015): 399-404. https://doi.org/10.3892/ijmm.2014.2015